Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -2,983 | -4,526 | N/A |
| Depreciation Amortization | 239 | 428 | N/A |
| Accounts receivable | -4 | 18 | N/A |
| Accounts payable and accrued liabilities | 5 | 77 | N/A |
| Other Working Capital | 154 | -253 | N/A |
| Other Operating Activity | 1,717 | 1,564 | 0 |
| Operating Cash Flow | $-872 | $-2,692 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1 | -11 | N/A |
| Other Investing Activity | 42 | -34 | 0 |
| Investing Cash Flow | $40 | $-45 | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | 2,244 | N/A |
| Debt Issued | 753 | N/A | N/A |
| Debt Repayment | -20 | -46 | N/A |
| Common Stock Issued | 88 | 366 | N/A |
| Other Financing Activity | 0 | 10 | 0 |
| Financing Cash Flow | $821 | $2,575 | $N/A |
| Beginning Cash Position | 25 | 187 | N/A |
| End Cash Position | 14 | 25 | N/A |
| Net Cash Flow | $-11 | $-162 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -872 | -2,692 | N/A |
| Capital Expenditure | -1 | -11 | N/A |
| Free Cash Flow | -873 | -2,703 | 0 |